Botanical species · safety record

Hoslundia opposita

The EFSA Compendium of Botanicals holds 32 constituent measurements and 2 adverse-effect records for Hoslundia opposita. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Hoslundia opposita Vahl

32Constituent measurements

2Safety records

9Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
(+)-pulegone	Leaves	Essential oil	≤ 1.3 Percent	GC-FID-MS	Resolve DOI
(+)-pulegone	Leaves	Essential oil	≥ 0.4 Percent	GC-FID-MS	Resolve DOI
(-)-globulol	Leaves	Essential oil	2.6 Percent	GC-MS	Resolve DOI
1,8-cineole	Leaves	Essential oil	≥ 1.3 Percent	GC-FID-MS	Resolve DOI
1,8-cineole	Leaves	Essential oil	≤ 2.4 Percent	GC-FID-MS	Resolve DOI
1,8-cineole	Leaves	Essential oil	≥ 0.2 Percent	GC-MS	Resolve DOI
1,8-cineole	Leaves	Essential oil	≤ 4.4 Percent	GC-MS	Resolve DOI
Camphor	Leaves	Essential oil	≥ 0.5 Percent	GC-MS	Resolve DOI
Camphor	Leaves	Essential oil	≤ 1 Percent	GC-MS	Resolve DOI
Diterpenes	Leaves	Essential oil	≥ 1.3 Percent	GC-FID-MS	Resolve DOI
Diterpenes	Leaves	Essential oil	≤ 5.9 Percent	GC-FID-MS	Resolve DOI
Epoxides	Leaves	Essential oil	≥ 0.8 Percent	GC-MS	Resolve DOI
Epoxides	Leaves	Essential oil	≤ 1 Percent	GC-MS	Resolve DOI
Eugenol	Leaves	Essential oil	≥ 55.1 Percent	GC-MS	Resolve DOI
Eugenol	Leaves	Essential oil	≤ 76.2 Percent	GC-MS	Resolve DOI
Menthofuran	Leaves	Essential oil	≥ 0.6 Percent	GC-FID-MS	Resolve DOI
Menthofuran	Leaves	Essential oil	≤ 3.9 Percent	GC-FID-MS	Resolve DOI
Menthone	Leaves	Essential oil	≤ 7 Percent	GC-FID-MS	Resolve DOI
Menthone	Leaves	Essential oil	≥ 1.6 Percent	GC-FID-MS	Resolve DOI
Pentacyclic triterpenic derivatives	Leaves	Solvent extraction	80 Milligram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
1,8-cineole	Fruit unspecified	Essential oil	1.2 Percent	GC-MS	No resolvable identifier
1,8-cineole	Leaves	Essential oil	72.3 Percent	GC-MS	No resolvable identifier
1,8-cineole	Leaves	Essential oil	72.3 Percent	GC-MS	No resolvable identifier
Alkaloids	Leaves	Solvent extraction	1.27 Percent	Phytochemical screening	No resolvable identifier
Anthraquinones	Unspecified	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Camphor	Fruit unspecified	Essential oil	69.5 Percent	GC-MS	No resolvable identifier
Cardiac glycosides	Unspecified	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Oxalates	Leaves	Solvent extraction	0.09 Percent	Phytochemical screening	No resolvable identifier
Proanthocyanidins (condensed tannins)	Unspecified	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Saponins	Unspecified	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Saponins	Leaves	Solvent extraction	5.8 Percent	Phytochemical screening	No resolvable identifier
Tannins	Unspecified	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Neurotoxicity	Neurologic: central nervous system	Roots and other underground parts	Solvent extraction	House mouse (as animal)	Acute toxicity	Resolve DOI
Neurotoxicity	Neurologic: central nervous system	Roots and other underground parts	Solvent extraction	House mouse (as animal)	Acute toxicity	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Ayedoun, MA., Adeoti, BS., Setondji, J., Tchoumbougnang, F., Kuiate, JR., Zollo, PHA., Menut, C., Lamaty, G., Bessiere, JM. Aromatic plants of tropical West Africa. XII. Essential oil of Hoslundia opposita Vahl. growing in Benin and Cameroon . Flavour and fragrance journal, 1999, vol. 14, no. 5, p. 319-321. DOI
Olajide, OA., Awe, SO., Makinde, JM. Central nervous system depressant effect of Hoslundia opposita Vahl. Phytotherapy research, 1999, vol. 13, no. 5, p. 425-426. DOI
Tonzibo, Z. F., Coffy, A. Ahibo., Chalachat, J. C., N'guessan, Y. T. Chemical composition of essential oils of Hoslundia opposita Vahl. from Ivory Coast. . Flavour and fragrance journal, 2006, vol. 21, no. 5, p. 789-791. DOI
Sharaibi, Olubunmi Josephine., Ogundipe, Oluwatoyin Temitayo., Afolayan, Anthony Jide., Aworinde, David Olaniran. Ethnobotanical survey and phytochemical analysis of medicinal plants used for the treatment of hyperprolactinemia in Lagos State, Nigeria. Journal of medicinal plants research, 2014, vol. 8, no. 43), 1284-128, p. 5 pp.
Ojo, O.O., Anibijuwon, I.I., Ojo, O.O. Studies on extracts of three medicinal plants of South-Western Nigeria: Hoslundia opposita, lantana camara and cymbopogon citratus. Advances in natural and applied sciences, 2010, vol. 4, no. 1, p. 93-98.
Mujovo, Silva F., Hussein, Ahmed A., Meyer, J. J. Marion., Fourie, B., Muthivhi, Tshilidzi., Lall, Namrita. Bioactive compounds from Lippia javanica and Hoslundia opposita. Natural product research, 2008, vol. 22, no. 12, p. 1047-1054. DOI
Usman, L. A., Zubair, M. F., Adebayo, S. A., Oladosu, I. A., Muhammad, N. O., Akolade, J. O. Chemical composition of leaf and fruit essential oils of Hoslundia opposita Vahl grown in Nigeria. American-eurasian journal of agricultural & environmental sciences, 2010, vol. 8, no. 1, p. 40-43.
Chagonda, LS., Chalchat, JC. The essential oil of wild and cultivated Hoslundia opposita Vahl. from Zimbabwe . Flavour and fragrance journal, 2005, vol. 20, no. 2, p. 193-195. DOI
Akolade, J. O., Muhammad, N. O., Usman, L. A., Odebisi, M. B., Sulyman, A. O., Akanji, F. T. Effects of essential oil extracted from the leaves of Hoslundia opposita V. on selected biochemical indices in rats. British journal of pharmacology and toxicology, 2014, vol. 5, no. 3, p. 109-114.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature